Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy

Pediatric Nephrology

Volumn 23, Issue 8, 2008, Pages 1257-1267

  Takamatsu, Masanori ^a   Urushihara, Maki ^a   Kondo, Shuji ^a   Shimizu, Maki ^a   Morioka, Tetsuo ^b   Oite, Takashi ^b   Kobori, Hiroyuki ^c   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

smooth muscle actin; Glomerular endothelial cells; Mesangial cells; Renin angiotensin system; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GLOMERULAR DYSFUNCTION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY CELL CULTURE; MALE; MESANGIUM CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SCORING SYSTEM; UPREGULATION; WESTERN BLOTTING;

ADOLESCENT; ALDEHYDES; ANGIOTENSIN II; ANGIOTENSINOGEN; CELL COUNT; CELLS, CULTURED; CHILD; ENDOTHELIAL CELLS; GENE EXPRESSION; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MESANGIAL CELLS; RENIN-ANGIOTENSIN SYSTEM; TRANSFORMING GROWTH FACTOR BETA; VASOCONSTRICTOR AGENTS;

EID: 46949084854     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0801-6     Document Type: Article

References (49)

1. Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000
2. Navar LG, Harrison-Bernard LM, Imig JD, Wang CT, Cervenka L, Mitchell KD (1999) Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol 10 (Suppl 12):S266-272
3. Nakamura N, Soubrier F, Menard J, Panthier JJ, Rougeon F, Corvol P (1985) Nonproportional changes in plasma renin concentration, renal renin content, and rat renin messenger RNA. Hypertension 7:855-859
4. Wagner J, Volk S, Haufe CC, Ciechanowicz A, Paul M, Ritz E (1995) Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection. J Am Soc Nephrol 5:1469-1475
5. Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437
6. Kagami S, Kuhara T, Okada K, Kuroda Y, Border WA, Noble NA (1997) Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 51:664-671
7. Ruiz-Ortega M, Egido J (1997) Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52:1497-1510
8. Mahmood J, Khan F, Okada S, Kumagai N, Morioka T, Oite T (2006) Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis. Kidney Int 70:1591-1598
9. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril efficacy in nephropathy. Lancet 352:1252-1256
10. Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S (2004) Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy. Hypertens Res 27:963-970
11. Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R (1998) Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 128:982-988
12. Coppo R, D, Amico G (2005) Factors predicting progression of IgA nephropathies. J Nephrol 18:503-512
13. Schena FP (1990) A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209-215
14. Yoshikawa N, Iijima K, Maehara K, Yoshiara S, Yoshiya K, Matsuo T, Okada S (1987) Mesangial changes in IgA nephropathy in children. Kidney Int 32:585-589
15. Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S (2004) Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int 46:576-579
16. Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S (2005) Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 64:35-40
17. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G (2003) Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64:149-159
18. Kobori H, Ozawa Y, Suzaki Y, Prieto-Carrasquro MC, Nishiyama A, Shoji T, Cohen EP, Navar LG (2006) Yong scholars award lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens 19:541-550
19. Lee LK, Meyer TW, Pollock AS, Lovett DH (1995) Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964
20. Singh R, Singh AK, Leehey DJ (2005) A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 288:F1183-F1190
21. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A (2005) Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16:2073-2080
22. Shin GT, Kim WH, Yim H, Kim MS, Kim H (2005) Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-α1 expression in acute ureteral obstruction. Kidney Int 67:897-908
23. Churg J, Bernstein J, Glassock R (1995) Classification of glomerular disease. In: Churg J, Bernstein J, Glassoch R (eds), Renal disease: classification and atlas of glomerular disease, 2nd end. Igaku-Shoin, New York, pp 1-23
24. Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S (2005) Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 25:1-12
25. Kuhara T, Kagami S, Kuroda Y (1997) Expression of b1-integrins on activated mesangial cells in human glomerulonephritis. J Am Soc Nephrol 8:1679-1687
26. Ballardie FW, Roberts IS (2002) Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 13:142-148
27. Kondo S, Shimizu M, Urushihara M, Tsuchiya K, Yoshizumi M, Tamaki T, Nishiyama A, Kawachi H, Shimizu F, Quinn MT, Lambeth DJ, Kagami S (2006) Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat. J Am Soc Nephrol 17:783-794
28. Abe K, Miyazaki M, Koji T, Furusu A, Nakamura-Kurashige T, Nishino T, Ozono Y, Harada T, Sakai H, Kohno S (2001) Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int 60:137-146
29. Suzaki Y, Ozawa Y, Kobori H (2006) Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides 27:3000-3002
30. Murakami S, Morioka T, Nakagawa Y, Suzuki Y, Arakawa M, Oite T (2001) Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: Comparison to human umbilical vein and dermal microvascular endothelial cells. Microvasc Res 62:383-391
31. Gimenez-Roqueplo AP, Celerier J, Lucarelli G, Corvol P, Jeunemaitre X (1998) Role of N-glycosylation in human angiotensinogen. J Biol Chem 273:21232-21238
32. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T, Walker BR (2003) Local and systemic impact of transcriptional up-regulation of 11b-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endorinol Metab 88:3983-3988
33. Kobori H, Harrison-Bernard LM, Navar LG (2001) Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12:431-439
34. Liebau MC, Lang D, Bohm J, Endlich N, Bek MJ, Witherden I, Mathieson PW, Saleem MA, Pavenstadt H, Fischer KG (2006) Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Phyiol 290:710-719
35. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM (1998) Gene expression of the renin-angiotensin system in human kidney. J Hypertens 16:91-102
36. Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC (2004) Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1. Kidney Int 66:1403-1416
37. Brewster UC, Perazella MA (2004) The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease. Am J Med 116:263-272
38. Hollenberg NK (1999) Pharmacologic interruption of the renin-angiotensin system and the kidney: Differential responses to angiotensin-converting enzyme and renin inhibition. J Am Soc Nephrol 10 (Suppl 11):S239-S242
39. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL (2004) Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15:1805-1815
40. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM (1991) Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858
41. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J (1996) Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885-892
42. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM (1992) Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474
43. Minutolo R, Balletta MM, Catapano F, Chiodini P, Tirino G, Zamboli P, Fuiano G, Russo D, Marotta P, Iodice C, Conte G, De Nicola L (2006) Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis. Kidney Int 70:1170-1176
44. Hernandez E, Toledo T, Alamo C, Mon C, Rodicio JL, Praga M (1997) Elevation of von Willebrand factor levels in patients with IgA nephropathy: Effect of ACE inhibition. Am J Kidney Dis 30:397-403
45. Kawasaki Y, Suzuki J, Nozawa R, Sakai N, Tannji M, Isome M, Suzuki H, Nozawa Y (2004) FB21, a monoclonal antibody that reacts with a sialic-acid-dependent carbohydrate epitope, is a marker for glomerular endothelial cell injury. Am J Kidney Dis 44:239-249
46. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S, Egido J (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82:12-22
47. Wolf G, Ziyadeh FN, Zahner G, Stahl RA (1996) Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 27:897-905
48. Cresci B, Giannini S, Pala L, Mavilia C, Manuelli C, Cappugi P, Maggi E, Rotella CM (2003) AT1 and AT2 receptors in human glomerular endothelial cells at different passages. Microvasc Res 66:22-29
49. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y (1990) IgA nephropathy in Japanese children and adults: A comparative study of clinicopathological features. Am J Nephrol 10:191-197